These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7546907)

  • 21. Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine.
    Agarwal RP; Wang W; Yo P; Han T; Fernandez M
    Biochem Pharmacol; 1999 Nov; 58(10):1603-8. PubMed ID: 10535751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
    Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
    J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular thymidine kinase activity is required for the inhibition of HIV-1 replication by AZT in lymphocytes.
    Lowy I; Caruso M; Goff SP; Klatzmann D
    Virology; 1994 Apr; 200(1):271-5. PubMed ID: 8128627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative active-site mutation study of human and Caenorhabditis elegans thymidine kinase 1.
    Skovgaard T; Uhlin U; Munch-Petersen B
    FEBS J; 2012 May; 279(10):1777-87. PubMed ID: 22385435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive nonradiometric method for determining thymidine kinase 1 activity.
    Ohrvik A; Lindh M; Einarsson R; Grassi J; Eriksson S
    Clin Chem; 2004 Sep; 50(9):1597-606. PubMed ID: 15247154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human inter-individual variability in metabolism and genotoxic response to zidovudine.
    Olivero OA; Ming JM; Das S; Vazquez IL; Richardson DL; Weston A; Poirier MC
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):158-64. PubMed ID: 18206198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arabinosylcytosine downregulates thymidine kinase and induces cross-resistance to zidovudine in T-lymphoid cells.
    Han T; Fernandez M; Sarkar M; Agarwal RP
    Biochem Biophys Res Commun; 2003 Aug; 307(3):564-8. PubMed ID: 12893260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2', 3'-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells.
    Han T; Fernandez M; Sarkar M; Agarwal RP
    Life Sci; 2004 Jan; 74(7):835-42. PubMed ID: 14659972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral and cellular factors for resistance against antiretroviral agents.
    Gröschel B; Cinatl J; Cinatl J
    Intervirology; 1997; 40(5-6):400-7. PubMed ID: 9675644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of a photoaffinity analog of 3'-azidothymidine, 5-azido-3'-azido-2',3'-dideoxyuridine. Interactions with herpesvirus thymidine kinase and cellular enzymes.
    Mao F; Rechtin TM; Jones R; Cantu AA; Anderson LS; Radominska A; Moyer MP; Drake RR
    J Biol Chem; 1995 Jun; 270(23):13660-4. PubMed ID: 7775417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
    Jackson JB
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidine kinase and deoxycytidine kinase in HIV-infected children.
    Falasca F; Maida P; Boni A; Bernardi S; Cursi L; Rizzo B; Antonelli G; Gattinara GC; Turriziani O
    New Microbiol; 2009 Oct; 32(4):411-3. PubMed ID: 20128449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene.
    Gröschel B; Höver G; Doerr HW; Cinatl J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine phosphorylation and mitochondrial toxicity in vitro.
    Sales SD; Hoggard PG; Sunderland D; Khoo S; Hart CA; Back DJ
    Toxicol Appl Pharmacol; 2001 Nov; 177(1):54-8. PubMed ID: 11708900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
    Barry M; Wild M; Veal G; Back D; Breckenridge A; Fox R; Beeching N; Nye F; Carey P; Timmins D
    AIDS; 1994 Aug; 8(8):F1-5. PubMed ID: 7986398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling.
    Christians FC; Scapozza L; Crameri A; Folkers G; Stemmer WP
    Nat Biotechnol; 1999 Mar; 17(3):259-64. PubMed ID: 10096293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells.
    Szebeni J; Patel SS; Hung K; Wahl LM; Weinstein JN
    Antimicrob Agents Chemother; 1991 Jan; 35(1):198-200. PubMed ID: 2014977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of azidothymidine therapy on pseudocholinesterase concentrations in asymptomatic HIV-positive patients.
    Barker GM; Holland C; Katz JA
    AANA J; 1994 Aug; 62(4):337-41. PubMed ID: 7810285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.